Navigation Links
Althea Technologies Secures $12 M Credit Line to Continue Facility Growth and Expansion
Date:9/16/2008

SAN DIEGO, Sept. 16 /PRNewswire/ -- Althea Technologies, Inc., a leading provider of innovative technologies and services for pharmaceutical development and manufacturing, announced today that it has secured a new credit facility through City National Bank to provide for additional capital investment in its newly constructed cGMP manufacturing plant. Althea intends to begin offering commercial manufacturing services in the fourth quarter of this year.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020925/LAW010LOGO)

"We are pleased to report the acquisition of this credit facility with City National Bank which will finance equipment for our recently constructed 30,000 SF cGMP commercial-scale manufacturing building. With truly state-of- the-art equipment, significant production capacities for biotech drugs and filling of finished drug products at the 100,000 unit batch size, this will enable Althea to advance to the next level as a major contract manufacturer. We look forward to working closely with the City National Bank team and are pleased with the attention and emphasis they have invested to this relationship," stated Dr. Magda Marquet, President and Co-CEO of Althea Technologies.

According to Gary Gilmore, Althea's CFO, the credit facility provides for $12 million of working capital and equipment financing for the new facilities.

Stephen Cusato, senior vice president and manager of City National Bank's Commercial Banking Services Office in San Diego, added, "We're excited to offer the bank's resources and our team's expertise to support Althea's expansion into commercial-scale manufacturing. We view this as the first step in a long-term relationship."

About Althea Technologies, Inc.

Althea Technologies, a leading San Diego-based pharmaceutical services firm, provides critical manufacturing services that support researchers worldwide
'/>"/>

SOURCE Althea Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. HealthEast Care System Selects Concuitys ClearContracts to Increase Contract Analysis and Negotiation Capabilities and Improve Revenue Cycle Management
2. Epeius Biotechnologies Lead Product, Rexin-G for Metastatic Cancer, Aptly Highlighted by National Cancer Institute Journal
3. Neptune Technologies decided not to re-price options
4. Neurobiological Technologies Announces Dates for 2008 Fiscal Year End Financial Results Conference Call and Presentation at MCF Investor Summit
5. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
6. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
7. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
8. Anthill Technologies Announces Agreement With Zafgen
9. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
10. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
11. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., BOCA RATON, Fla., Nov. 25 For...t so for BodyLogicMD. The nation,s largest and fa...izing exclusively in medically supervised bioiden...ians in its network since November 2008 - from ...ore physician-owned centers, including one in Puer...
(Date:11/25/2009)...PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (...t, Pharm.D., president and chief executive officer...alth Care Conference. , ,Presentation details are...e Conference,Date: Tuesday, December 1, 2009,...ew York Palace Hotel, New York, NY,Webcast: <a ...
(Date:11/24/2009)... York investment bank KTA Capital,s client Neuren ... mil convertible note private placement with a U.S...s arranged by KTA Capital as Neuren,s exclusive pl... New York (PRWEB) November 23, 2009 -- The inde...("KTA Capital") has announced that its c...
(Date:11/24/2009)... Sigma-Aldrich Corporati...AQ OMX conference on Tuesday, December 1st at 1:45...ies may listen via live audio broadcast over the I... a a ldrich.com/ . Users can click the "Webcas...-Aldrich: Sigma-Aldrich is a leading Life Scienc...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 4Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...th quarter gross profit grows by nearly 90%, opera.... 25 VirtualScopics, Inc. (Nasdaq: VSCP ), a le...l trials, announced today that revenues for the fo... increase over prior year,s fourth quarter. Revenu...ximately $7.1 million compared to $5.6 million in ...
...AN FRANCISCO, Feb. 25 VIA Pharmaceuticals, Inc. (...on the development of compounds for the treatment ...ounced the issuance of United States Patent No. 7,...ombating Atherosclerotic Plaque", covering the use...nt of atherosclerosis. This patent is also pendin...
... REINACH, Switzerland, February 25 Arpida Ltd,(...or the year ending 31,December 2008. , , 2008 K...r intravenous iclaprim in US, - Restructuring... "intravenous-to-oral" Phase II trial with oral, ...hare placing, Cash and financial investments of...
Other Biology Technology:VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit 2VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit 3VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit 4VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit 5VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit 6VirtualScopics Achieves Operating Cash Flow Breakeven in the Fourth Quarter 2008; Reports Record 2008 Revenue and Gross Profit 7VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291 2VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291 3VIA Pharmaceuticals Announces Grant of New Patent on Lead Compound VIA-2291 4Arpida Announces Full Year 2008 Financial Results 2Arpida Announces Full Year 2008 Financial Results 3Arpida Announces Full Year 2008 Financial Results 4Arpida Announces Full Year 2008 Financial Results 5
(Date:11/25/2009)...niversity assistant professors recently received f...to continue research beneficial to understanding t..., Christopher Blackwood, assistant professor in t...grants to support two separate research projects. ...ecomposer Communities and Functions from the Leaf ...
(Date:11/24/2009)... years it has been prescribed by traditional heale...daches and stomach pain to fever and flu. , Now f...sity have been able to scientifically prove the pa...wise known as Brazilian mint. , Testing this anci...esearcher Graciela Rocha was able to show that whe...
(Date:11/24/2009)...s opening new doors to understanding how sounds as...of a marine mammal or if they hear it at all. , ...nners that NASA uses to detect flaws in the space ...ing scientists to peek inside the giant head of a ...nsional replicas of a whale,s hearing anatomy usin...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Rare disorder gives modelers first glimpse at immune system development 49096 1Rare disorder gives modelers first glimpse at immune system development 49096 2Spinal Decompression Therapy Offers Hope for Back Pain 49093 1Spinal Decompression Therapy Offers Hope for Back Pain 49093 2Association for Molecular Pathology comments to the SACGHS 49088 1Association for Molecular Pathology comments to the SACGHS 49088 2
...a part of the National Institutes of Health, is pr...ers of one of the twentieth century’s greatest sci... Web site. , ,Don,t miss Crick,s sketch of the D...ofiles in Science represents a close collaboration...Wellcome Library for the History and Understanding...
..., a novel,vaccine that uses immune cells as factor... treat some human breast cancers, say researchers ...enter. [Ed : Her2/neu is a protein often present...ublished in the online journal, Breast Cancer Rese...otected 86 percent of,experimental mice against HE...
...nal Nature that the "missing" genes for tRNA in an... sequences in distant parts of the DNA genome. , ...epartment of Molecular Biophysics and Biochemistry... a known genome sequence. Nanoarchaeum equitans, i...chaea containing organisms that are primitive, par...
Other Biology News:Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 2Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 3A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020 2A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020 3Researchers find missing genes of ancient organism 2
Rabbit Anti-Human GORASP2 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
FailSafe PCR 2X PreMix B from EPICENTRE Biotechnologies
Rat Whole Blood Non-Sterile Alsevers from Pel-Freez Biologicals
Anti-Endomorphin-2 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: